Floyd L J, Barnes L D, Williams R F
Department of Biochemistry, University of Texas Health Science Center San Antonio 78284-7760.
Biochemistry. 1989 Oct 17;28(21):8515-25. doi: 10.1021/bi00447a037.
A new photoaffinity analogue of colchicine, (2-nitro-4-azidophenyl)deacetylcolchicine (NAPDAC), bound to two classes of sites on bovine renal tubulin and photolabeled both the alpha- and beta-subunits. The apparent Ki for the photoaffinity analogue was 1.40 +/- 0.17 microM (mean +/- SD, n = 3) as measured by competition with [3H] colchicine. Values of the apparent KdS for the two sites, as measured by the direct binding of the [3H]NAPDAC to tubulin, were 0.48 +/- 0.11 microM and 11.6 +/- 3.5 microM (mean +/- SD, n = 6), and the corresponding stoichiometries of binding of the two sites were 0.25 +/- 0.06 and 1.3 +/- 0.4 mol/mol of tubulin (mean +/- SD, n = 6). NAPDAC was a potent inhibitor of microtubule formation as detected by electron microscopy. When tubulin was photolabeled with NAPDAC at 25 degrees C, 15 +/- 3 mol % (mean +/- SD, n = 6) of the [3H]NAPDAC was covalently bound to the alpha-subunit, and 67 +/- 9 mol % (mean +/- SD, n = 6) was covalently bound to the beta-subunit. Since NAPDAC is a mixture of two interconvertible diastereomers, the photoincorporation of each was also examined. One diastereomer photolabeled both alpha- and beta-tubulin; however, the other did not significantly photolabel either subunit. Tubulin photolabeled with NAPDAC (1:1 mole ratio) exhibited a 23% decrease in colchicine binding. Preblocking and prephotolysis experiments with colchicine, NAPDAC, or ANPAH-CLC [Williams et al. (1985) J. Biol. Chem. 260, 13794-13802] provided evidence for conformational changes in tubulin upon colchicine binding. Peptide maps of [3H]NAPDAC-labeled alpha- and beta-tubulin, using Staphylococcus aureus V8 protease, demonstrated the presence of NAPDAC in one peptide of the alpha-subunit and in five peptides of the beta-subunit as detected by autoradiography. NAPDAC provides the first direct evidence for two colchicine binding sites on tubulin.
秋水仙碱的一种新的光亲和类似物,(2-硝基-4-叠氮基苯基)去乙酰秋水仙碱(NAPDAC),与牛肾小管微管蛋白上的两类位点结合,并对α和β亚基进行了光标记。通过与[3H]秋水仙碱竞争测定,该光亲和类似物的表观Ki为1.40±0.17微摩尔(平均值±标准差,n = 3)。通过[3H]NAPDAC与微管蛋白的直接结合测定,两个位点的表观KdS值分别为0.48±0.11微摩尔和11.6±3.5微摩尔(平均值±标准差,n = 6),两个位点结合的相应化学计量比分别为0.25±0.06和1.3±0.4摩尔/摩尔微管蛋白(平均值±标准差,n = 6)。通过电子显微镜检测,NAPDAC是微管形成的有效抑制剂。当微管蛋白在25℃用NAPDAC进行光标记时,15±3摩尔%(平均值±标准差,n = 6)的[3H]NAPDAC共价结合到α亚基上,67±9摩尔%(平均值±标准差,n = 6)共价结合到β亚基上。由于NAPDAC是两种可相互转化的非对映异构体的混合物,还对每种异构体的光掺入情况进行了研究。一种非对映异构体对α和β微管蛋白都进行了光标记;然而,另一种异构体对任何一个亚基都没有明显的光标记。用NAPDAC(1:1摩尔比)光标记的微管蛋白秋水仙碱结合能力下降了23%。用秋水仙碱、NAPDAC或ANPAH-CLC进行预阻断和预光解实验[威廉姆斯等人(1985年)《生物化学杂志》260,13794 - 13802]为秋水仙碱结合后微管蛋白的构象变化提供了证据。使用金黄色葡萄球菌V8蛋白酶对[3H]NAPDAC标记的α和β微管蛋白进行肽图分析,通过放射自显影检测到α亚基的一个肽段和β亚基的五个肽段中存在NAPDAC。NAPDAC为微管蛋白上的两个秋水仙碱结合位点提供了首个直接证据。